Skip to main content
Erschienen in: Intensive Care Medicine 5/2016

15.07.2015 | What's New in Intensive Care

Biomarkers of ARDS: what’s new?

verfasst von: Lorraine B. Ware, Carolyn S. Calfee

Erschienen in: Intensive Care Medicine | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Excerpt

Despite hundreds of studies of biomarkers in the acute respiratory distress syndrome (ARDS), there are no biomarkers of ARDS in use in clinical practice [1]. A recent meta-analysis highlights some of the limitations of current studies: small sample sizes, inadequate and inconsistent controls, and lack of large validation studies for many biomarkers [2]. Nevertheless, recent progress in several areas of biomarker research, including advances in the development of point-of-care testing technologies, has the potential to transform the application of biomarkers to clinical ARDS and may soon lead to the use of biomarkers at the bedside for diagnosis, risk stratification, and molecular phenotyping. …
Literatur
1.
Zurück zum Zitat Janz DR, Ware LB (2013) Biomarkers of ALI/ARDS: pathogenesis, discovery, and relevance to clinical trials. Semin Respir Crit Care Med 34(4):537–548CrossRefPubMed Janz DR, Ware LB (2013) Biomarkers of ALI/ARDS: pathogenesis, discovery, and relevance to clinical trials. Semin Respir Crit Care Med 34(4):537–548CrossRefPubMed
2.
Zurück zum Zitat Terpstra ML, Aman J, van Nieuw Amerongen GP, Groeneveld AB (2014) Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 42(3):691–700CrossRefPubMed Terpstra ML, Aman J, van Nieuw Amerongen GP, Groeneveld AB (2014) Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 42(3):691–700CrossRefPubMed
3.
Zurück zum Zitat Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Makita K et al (2006) Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 173(9):1008–1015CrossRefPubMedPubMedCentral Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Makita K et al (2006) Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 173(9):1008–1015CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Jabaudon M, Blondonnet R, Roszyk L, Bouvier D, Audard J, Clairefond G et al (2015) Soluble RAGE predicts impaired alveolar fluid clearance in acute respiratory distress syndrome. Am J Respir Crit Care Med. doi:10.1164/rccm.201501-0020OC Jabaudon M, Blondonnet R, Roszyk L, Bouvier D, Audard J, Clairefond G et al (2015) Soluble RAGE predicts impaired alveolar fluid clearance in acute respiratory distress syndrome. Am J Respir Crit Care Med. doi:10.​1164/​rccm.​201501-0020OC
5.
Zurück zum Zitat Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wickersham N et al (2008) Plasma receptor for advanced glycation end-products and clinical outcomes in acute lung injury. Thorax 63:1083–1089CrossRefPubMedPubMedCentral Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wickersham N et al (2008) Plasma receptor for advanced glycation end-products and clinical outcomes in acute lung injury. Thorax 63:1083–1089CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT et al (2010) Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 137(2):288–296CrossRefPubMedPubMedCentral Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT et al (2010) Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 137(2):288–296CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Fremont RD, Koyama T, Calfee CS, Wu W, Dossett LA, Bossert FR et al (2010) Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis. J Trauma 68(5):1121–1127CrossRefPubMedPubMedCentral Fremont RD, Koyama T, Calfee CS, Wu W, Dossett LA, Bossert FR et al (2010) Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis. J Trauma 68(5):1121–1127CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Brown RM, Semler MW, Zhao Z, Koyama T, Janz DR, May AK et al (2015) Plasma angiopoietin-2 (Ang2) and receptor for advanced glycation end products (RAGE) improve diagnosis of ARDS compared to provider clinical assessment in adult trauma patients. Am J Respir Crit Care Med 191:A4417 Brown RM, Semler MW, Zhao Z, Koyama T, Janz DR, May AK et al (2015) Plasma angiopoietin-2 (Ang2) and receptor for advanced glycation end products (RAGE) improve diagnosis of ARDS compared to provider clinical assessment in adult trauma patients. Am J Respir Crit Care Med 191:A4417
9.
Zurück zum Zitat Ware LB, Koyama T, Zhao Z, Janz DR, Wickersham N, Bernard GR et al (2013) Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome. Crit Care 17(5):R253CrossRefPubMedPubMedCentral Ware LB, Koyama T, Zhao Z, Janz DR, Wickersham N, Bernard GR et al (2013) Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome. Crit Care 17(5):R253CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Schnapp LM, Donohoe S, Chen J, Sunde DA, Kelly PM, Ruzinski J et al (2006) Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury. Am J Pathol 169(1):86–95CrossRefPubMedPubMedCentral Schnapp LM, Donohoe S, Chen J, Sunde DA, Kelly PM, Ruzinski J et al (2006) Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury. Am J Pathol 169(1):86–95CrossRefPubMedPubMedCentral
11.
12.
Zurück zum Zitat Gerszten RE, Accurso F, Bernard GR, Caprioli RM, Klee EW, Klee GG et al (2008) Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI clinical proteomics programs. Am J Physiol Lung Cell Mol Physiol 295(1):L16–L22CrossRefPubMedPubMedCentral Gerszten RE, Accurso F, Bernard GR, Caprioli RM, Klee EW, Klee GG et al (2008) Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI clinical proteomics programs. Am J Physiol Lung Cell Mol Physiol 295(1):L16–L22CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat McVey M, Tabuchi A, Kuebler WM (2012) Microparticles and acute lung injury. Am J Physiol Lung Cell Mol Physiol 303(5):L364–L381CrossRefPubMed McVey M, Tabuchi A, Kuebler WM (2012) Microparticles and acute lung injury. Am J Physiol Lung Cell Mol Physiol 303(5):L364–L381CrossRefPubMed
15.
Zurück zum Zitat Calfee CS, Janz DR, Bernard GR, May AK, Kangelaris KN, Matthay MA et al (2015) Distinct molecular phenotypes of direct vs indirect ards in single-center and multicenter studies. Chest 147(6):1539–1548CrossRefPubMed Calfee CS, Janz DR, Bernard GR, May AK, Kangelaris KN, Matthay MA et al (2015) Distinct molecular phenotypes of direct vs indirect ards in single-center and multicenter studies. Chest 147(6):1539–1548CrossRefPubMed
16.
Zurück zum Zitat Schmidt EP, Yang Y, Janssen WJ, Gandjeva A, Perez MJ, Barthel L et al (2012) The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med 18(8):1217–1223CrossRefPubMed Schmidt EP, Yang Y, Janssen WJ, Gandjeva A, Perez MJ, Barthel L et al (2012) The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med 18(8):1217–1223CrossRefPubMed
17.
Zurück zum Zitat Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M et al (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351(4):327–336CrossRefPubMed Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M et al (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351(4):327–336CrossRefPubMed
18.
Zurück zum Zitat Wong HR, Cvijanovich NZ, Allen GL, Thomas NJ, Freishtat RJ, Anas N et al (2011) Validation of a gene expression-based subclassification strategy for pediatric septic shock. Crit Care Med 39(11):2511–2517CrossRefPubMedPubMedCentral Wong HR, Cvijanovich NZ, Allen GL, Thomas NJ, Freishtat RJ, Anas N et al (2011) Validation of a gene expression-based subclassification strategy for pediatric septic shock. Crit Care Med 39(11):2511–2517CrossRefPubMedPubMedCentral
Metadaten
Titel
Biomarkers of ARDS: what’s new?
verfasst von
Lorraine B. Ware
Carolyn S. Calfee
Publikationsdatum
15.07.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 5/2016
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-015-3973-0

Weitere Artikel der Ausgabe 5/2016

Intensive Care Medicine 5/2016 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.